Amneal Pharmaceuticals EBITDA Margin Growth & History (AMRX)

Amneal Pharmaceuticals's ebitda margin was 20.46% for fiscal 2025.

View full Amneal Pharmaceuticals company overview

Amneal Pharmaceuticals annual ebitda margin history

Amneal Pharmaceuticals annual ebitda margin

Fiscal yearPeriod endedEBITDA marginChange (percentage points)
20252025-12-3120.46%+3.08 pp
20242024-12-3117.38%−0.74 pp
20232023-12-3118.12%+11.56 pp
20222022-12-316.57%−11.88 pp
20212021-12-3118.44%+2.05 pp
20202020-12-3116.39%+18.94 pp
20192019-12-31−2.55%−13.90 pp
20182018-12-3111.35%−23.49 pp
20172017-12-3134.83%+3.61 pp
20162016-12-3131.22%

Amneal Pharmaceuticals ebitda margin trends

Over the last five fiscal years, Amneal Pharmaceuticals's ebitda margin increased from 16.39% to 20.46%, a change of +4.07 percentage points. The latest reported quarter, Q2 2026, shows 21.83%.

About the metric

What EBITDA margin means

EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.

Calculation and source

How EBITDA margin is calculated

TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Amneal Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about AMRX yet. Start the conversation.

Write the first post